The Iguratimod Effect on Lupus Nephritis (IGeLU)

Clinical trial NCT02936375 · UNKNOWN

Trial details

NCT number: NCT02936375
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2017-09-07
Primary completion: 2020-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.